Read More Pharma Industry News Takeda’s TAKHZYRO approved by EC for pediatric hereditary angioedema Takeda has announced a significant advancement in the treatment of Hereditary Angioedema (HAE), with the European Commission’s approval… byPallavi MadhirajuNovember 18, 2023